Skip to content
Longevity Venture Partners logo
Venture CapitalExempt Reporting Adviser · CRD 326760Private Fund Adviser

Updated:

Longevity Venture Partners

Longevity Venture Partners is an American early-stage venture capital fund specializing in the Silvertech, Healthcare and Wellness sectors. CommuniCare...

Overview

Longevity Venture Partners is an American early-stage venture capital fund specializing in the Silvertech, Healthcare and Wellness sectors. CommuniCare Family of Companies is Longevity’s parent company and a major U.S. health care enterprise with more than 90 facilities in the U.S.

General information

Firm type

Venture Capital

Year founded

2020

Location

Region

North America

Country

United States

City

Pikesville

Corporate office

Baltimore, MD, United States

Sector focus

Digital HealthAI/MLEnterprise SoftwareHealthcare Services

Frequently asked questions

What is Longevity Venture Partners' core investment thesis?

The firm concentrates exclusively on extending healthy human lifespan through early-stage venture investments. Its thesis targets the biology of aging across therapeutic development, diagnostic platforms, and AI-enabled drug discovery. This pure-play approach means it does not diversify into general biotech or healthtech sectors outside the longevity umbrella.

Does Longevity Venture Partners lead rounds or participate as a co-investor?

The firm's participation posture is not publicly confirmed. Early-stage longevity vehicles of similar size often prefer co-investment or syndicate participation alongside larger biotech funds. Without direct disclosure, the firm's lead-investor appetite remains unverified.

Which sectors does Longevity Venture Partners explicitly avoid?

By structural design, the firm avoids any sector outside the longevity economy. This excludes general biotechnology, medical devices not directly tied to aging mechanisms, late-stage pharmaceuticals, and health IT platforms without a geroscience or lifespan-extension component.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Venture Capital profiles